SkinBioTherapeutics Plc (SBTX.L)
GBp 20.05
(-2.2%)
GBp 20.05
(-2.2%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | -2.99 Million GBP | -0.62% |
| 2021 | -2.98 Million GBP | -99.48% |
| 2020 | -1.49 Million GBP | 7.76% |
| 2019 | -1.62 Million GBP | -19.23% |
| 2018 | -1.35 Million GBP | -44.37% |
| 2017 | -941.19 Thousand GBP | -39.91% |
| 2016 | -672.69 Thousand GBP | -15916.64% |
| 2015 | -4200.00 GBP | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q2 | -1.38 Million GBP | 0.0% |
| 2022 Q4 | -1.64 Million GBP | 0.0% |
| 2022 Q2 | -1.35 Million GBP | 0.0% |
| 2022 FY | -2.99 Million GBP | -0.62% |
| 2021 Q2 | -1.15 Million GBP | 0.0% |
| 2021 FY | -2.98 Million GBP | -99.48% |
| 2021 Q4 | -1.82 Million GBP | 0.0% |
| 2020 Q2 | -628.24 Thousand GBP | 0.0% |
| 2020 FY | -1.49 Million GBP | 7.76% |
| 2020 Q4 | -868.87 Thousand GBP | 0.0% |
| 2019 Q4 | -731.04 Thousand GBP | 0.0% |
| 2019 FY | -1.62 Million GBP | -19.23% |
| 2019 Q2 | -889 Thousand GBP | 0.0% |
| 2018 Q4 | -728.2 Thousand GBP | 0.0% |
| 2018 FY | -1.35 Million GBP | -44.37% |
| 2018 Q2 | -632.27 Thousand GBP | 0.0% |
| 2017 FY | -941.19 Thousand GBP | -39.91% |
| 2017 Q4 | -554.92 Thousand GBP | 0.0% |
| 2017 Q2 | -386.52 Thousand GBP | 0.0% |
| 2016 Q3 | -115.28 Thousand GBP | 35.41% |
| 2016 FY | -672.69 Thousand GBP | -15916.64% |
| 2016 Q2 | -178.5 Thousand GBP | -100.0% |
| 2016 Q1 | -89.25 Thousand GBP | 0.0% |
| 2016 Q4 | -282.72 Thousand GBP | -145.23% |
| 2015 FY | -4200.00 GBP | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|